Showing results (201-210 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|July 28, 2022
Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation RadiopharmaceuticalGuldem Mercanoglu, Kani Zilbeyaz, Nuri ArslanCurrent Radiopharmaceuticals|June 30, 2018
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution ExperienceKalevi Kairemo, Denai R Milton, Elba Etchebehere, et al.Current Radiopharmaceuticals|August 18, 2018
Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal HemorrhagePierpaolo Alongi, Ignazio Gaspare Vetrano, Elisa Fiasconaro, et al.Current Radiopharmaceuticals|March 22, 2023
A Computed Tomography-based Radiomics Analysis of Low-energy Proximal Femur Fractures in the Elderly PatientsSeyed Mohammad Mohammadi, Samir Moniri, Payam Mohammadhoseini, et al.Current Radiopharmaceuticals|February 28, 2023
Promising Radiopharmaceutical Tracers for Detection of Cardiotoxicity in Cardio-oncologyZahra Shaghaghi, Fatemeh Jalali Zefrei, Arsalan Salari, et al.Current Radiopharmaceuticals|January 23, 2025
Harnessing Radionuclides: Unveiling the Promising Role of Radiopharmaceuticals in Cancer Theranostics and Palliative CareMihai Cozmin, Ionut Iulian Lungu, Radu Cernei, et al.Current Radiopharmaceuticals|September 3, 2024
An Analysis of the Radiosensitiser Applications in the Biomedical FieldTeng Sheng Lim, Irman Abdul Rahman, Aminah Umar, et al.Current Radiopharmaceuticals|May 2, 2024
Biological Efficacy of Ionizing Radiation Sources on 3D Organotypic Tissue Slices Assessed by Fluorescence MicroscopyVictoria Shestakova, Anna Smirnova, Anna Yakimova, et al.Current Radiopharmaceuticals|April 30, 2024
Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 ProteinsImran Khan, Sadaf Mahfooz, Busra Karacam, et al.Current Radiopharmaceuticals|April 30, 2024
Radiopharmaceuticals Adverse Events ManagementAna Agudo Martínez, Gertrudis Sabatel Hernandez, Manuela Molina Mora, et al.Pageof 46